Posible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report

Posible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report

Bibliographic Details
Main Authors:	P. Selvi Sabater, A. M. Rizo Cerdá, J. C. Titos Arcos, A. Espuny Miró
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2014-05-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/7279.pdf

Similar Items

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw
by: Sandra Bacián Martínez, et al.
Published: (2021-08-01)

Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
by: Higuchi, T., et al.
Published: (2018)

Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case
by: Mohammed Qaisi, et al.
Published: (2016-01-01)

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
by: Marília A. Figueiredo, et al.
Published: (2021-01-01)

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
by: Sung-mok Jung, et al.
Published: (2018-07-01)

Denosumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2017-03-01)

Osteonecrosis of the jaw and bilateral atypical femoral fractureboth occurring during treatment for osteoporosis
by: E.F. Payumo, et al.
Published: (2017-09-01)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva<sup>®</sup>) Related Osteonecrosis of the Jaw: A Retrospective Study
by: Zineb Assili, et al.
Published: (2021-05-01)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Bisphosphonates and osteonecrosis of the jaw: a case report
by: André Borba Reiriz, et al.
Published: (2008-01-01)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
by: Gianfranco Favia, et al.
Published: (2016-01-01)

Advantages of using denosumab for osteoporosis
by: O. B. Ershova, et al.
Published: (2013-12-01)

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)

Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review
by: Alessandra Raimondi, et al.
Published: (2020-10-01)

A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers
by: Satoe Okuma, et al.
Published: (2020-05-01)

Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
by: Young-Ho Shim, et al.
Published: (2021-08-01)

A review of denosumab for the treatment of osteoporosis
by: Miyazaki T, et al.
Published: (2014-04-01)

Osteoporosis in men: epidemiology and treatment with denosumab
by: Sidlauskas KM, et al.
Published: (2014-04-01)

Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report
by: Ehrenfeld Michael, et al.
Published: (2011-09-01)

Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study
by: Kye Hwa Lee, et al.
Published: (2019-11-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012-01-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Osteonecrosis of the jaw in association to bisphosphonates
by: Mattos, Ana Carolina Lopes
Published: (2020)

Should denosumab treatment for osteoporosis be continued indefinitely?
by: Jane A. Noble, et al.
Published: (2021-04-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Bisphosphonate related osteonecrosis of jaw: A case report
by: Waquar Ahmed, et al.
Published: (2017-01-01)

Denosumab treatment in patients with different courses of osteoporosis
by: Liudmila Ya. Rozhinskaya, et al.
Published: (2017-12-01)

Bisphosphonates-induced osteonecrosis of the jaw: pharmacology and clinical procedures.
by: Candice Belchior Duplat, et al.
Published: (2012-01-01)

BISPHOSPHONATES-INDUCED OSTEONECROSIS OF THE JAW: PHARMACOLOGY AND CLINICAL PROCEDURES.
by: Candice Belchior Duplat, et al.
Published: (2012-08-01)

Oroantral fistula from bisphosphonate induced osteonecrosis of the jaw
by: Henry Sharp, et al.
Published: (2010-07-01)

Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients
by: Gammelager H, et al.
Published: (2013-08-01)

Osteonecrosis of Jaw: Common etiologies, uncommon treatments
by: Panta, Utsab, et al.
Published: (2019)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Treatment of bisphosphonate-related osteonecrosis of the jaws – a report of seven cases
by: Joanna Jakiel, et al.
Published: (2017-01-01)